(Q45411290)

English

The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunity

scientific article published in November 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunity (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S Greiner

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

J Y Humrich

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

P Thuman

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

B Sauter

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

G Schuler

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

L Jenne

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

publication date

1 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

146

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

344-353

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Tumor-specific shared antigenic peptides recognized by human T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

A clinical histologic, and immunologic study of a case of metastatic malignant melanoma undergoing spontaneous remission

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Human T cell responses against melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Intradermal injection of Newcastle disease virus-modified autologous melanoma cell lysate and interleukin-2 for adjuvant treatment of melanoma patients with resectable stage III disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Overview analysis of adjuvant therapies for melanoma--a special reference to results from vaccinia melanoma oncolysate adjuvant therapy trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Immunotherapy of Malignant Melanoma With Vaccinia Virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Viral vectors for dendritic cell-based immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Dendritic cells resurrect antigens from dead cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Nonreplicating vaccinia vector efficiently expresses recombinant genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Viral transport and the cytoskeleton

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Antigen loading of dendritic cells with whole tumor cell preparations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Elucidation of the molecular mechanism underlying tumor-selective replication of the oncolytic adenovirus mutant ONYX-015.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Oncolytic viral therapies - the clinical experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Tumour-cell invasion and migration: diversity and escape mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Dendritic cells as vectors for therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03177.X

21 January 2018

Proteolytic and non-proteolytic migration of tumour cells and leucocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1942054

27 August 2018

Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1942054

27 August 2018

A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1942054

27 August 2018

Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1942054

27 August 2018

Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1942054

27 August 2018

Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1942054

27 August 2018

A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1942054

27 August 2018

Viral vectors for dendritic cell-based immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17034588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VIRUSES IN THE TREATMENT OF CANCER

1 reference

https://pubmed.ncbi.nlm.nih.gov/17034588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17034588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Viral oncolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17034588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: results of a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17034588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

https://pubmed.ncbi.nlm.nih.gov/17034588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T Helper 1 Cytokine mRNA Is Increased in Spontaneously Regressing Primary Melanomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17034588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2249.2006.03177.X

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45411290&oldid=2076839197"